Low Cost Modular Tissue Microarray Instrument
低成本模块化组织微阵列仪器
基本信息
- 批准号:8648208
- 负责人:
- 金额:$ 74.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-17 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:Applications GrantsBiological AssayClinicalClinical ResearchCustomDevelopmentDevicesFluorescent in Situ HybridizationFosteringFreezingGoalsHealthHeatingHematoxylin and Eosin Staining MethodHistologyImmunohistochemistryInjection of therapeutic agentLegal patentMarketingMedicalMethodsMicroscopeMicrotome - medical deviceMoldsNeedlesParaffinPathologyPatternPerformancePhasePlasticsPriceProductionProgram DevelopmentResearchResearch PersonnelResortSalesSamplingSlideStaining methodStainsSystemTechnologyTestingTissue MicroarrayTissuesValidationVisionWorkbasecancer diagnosisclinical applicationcommercial applicationcommercializationcostdesignergonomicsinstrumentlaboratory facilitymeetingsnovelphase 1 studyprogramsprototypesuccesstool
项目摘要
PROJECT SUMMARY
NAME, ADDRESS, AND TELEPHONE NUMBER OF OFFEROR ORGANIZATION
Micatu, Incorporated
109 Canada Road
Painted Post, New York 14870
Office: 1-888-705-8836
Fax: 1-888-715-8672
AGENCY NAME:
NCI- DHHS/NIH
SOLICITATION NUMBER:
PHS 2013-2
TOPIC NUMBER:
TITLE OF PROJECT
Semi-Automated, Heated and Cooled Tissue Microarray Construction Instrument
KEY PERSONNEL ENGAGED ON PROJECT
Name (First, Middle, Last)
Michael Jagielski
Atul, Pradhan Ph.D
Michael Oshetski
John Oshetski
Jiaoti Haung, M.D., Ph.D.
ORGANIZATION
Micatu, Inc.
Micatu, Inc.
Micatu, Inc.
Micatu, Inc.
POSITION TITLE
Project Director
Lead Scientist
Sr. Engineer
Sr. Engineer
Director of Urologic Pathology
UCLA
ABSTRACT:
The objective for the Phase I study was to design and build a low cost Tissue Microarray (TMA) device that would meet
market demands for high quality, fast TMA construction. To that end Micatu Inc. has successfully developed a
production ready TMA device and kit (MicaArray) that has successfully demonstrated H&E stained TMAs featuring
90% alignment of sample cores to the recipient block, 95% sample core perpendicular placement , and 100%
compliance to required TMA sectioning count. Micatu's Phase II development program will continue on these successes
and rapid progress to provide an affordable, turnkey instrument suite that further expands investigators' ability to
construct their own TMAs without resorting to expensive core laboratory facilities as well as allow for the efficient,
reliable, and low cost construction of TMAs for validation and use in research and clinical settings. This will foster a
proliferation of applications in fields such as pathology, histology, IHC controls, and cancer diagnosis, having major
medical impact. The MicaArray vision represents a simple, yet powerful concept based on seamless integration,
precision fabrication, and optimization of tools for constructing TMAs. The Phase II research plan will refine the novel
alignment template that registers and guides the coring needle at highly precise intervals, design and build a novel,
ergonomic, and versatile coring and injection needle with a threaded needle system that allows for a single handle for
both extraction of the donor block cores and injection into recipient block, prove out with design verification testing a low
cost rugged construction of the MicaArray device using machinable or injection molded plastic for volume production
and manufacturability, provide a custom low cost mold for casting TMA blocks, design build and install an integrated
Thermoelectric Cooler (TEC)/Heater that can directly heat and cool donor and recipient blocks thereby providing a new,
powerful, and heretofore unavailable capability to electronically control and devise thermal cycling sequences that are
optimum for both paraffin and cryo (frozen) embedded TMA construction, and commercialize the MicaArray kit at a
sales price that is 30x less than any commercially available instrument.
Key words to identify the research or technology:
Tissue, microarray, staining, paraffin, cryo, recipient block, donor block, template, Coring Needle, TMA
Brief summary of the potential commercial applications of the research:
Micatu, Inc. research plan provides commercialization potential to the academic, clinical and research
markets
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael T Jagielski其他文献
Michael T Jagielski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael T Jagielski', 18)}}的其他基金
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 74.92万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 74.92万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 74.92万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 74.92万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 74.92万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 74.92万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 74.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 74.92万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 74.92万 - 项目类别:
Postdoctoral Fellowships